Boyer-Guittaut Michaël, Birsoy Kivanç, Potel Corinne, Elliott Gill, Jaffray Ellis, Desterro Joanna M, Hay Ron T, Oelgeschläger Thomas
Transcription Laboratory, Marie Curie Research Institute, Oxted, Surrey RH8 0TL, UK.
J Biol Chem. 2005 Mar 18;280(11):9937-45. doi: 10.1074/jbc.M414149200. Epub 2005 Jan 6.
The TFIID complex is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAFs) and is the only component of the general RNA polymerase II (RNAP II) transcription machinery with intrinsic sequence-specific DNA-binding activity. Binding of transcription factor (TF) IID to the core promoter region of protein-coding genes is a key event in RNAP II transcription activation and is the first and rate-limiting step of transcription initiation complex assembly. Intense research efforts in the past have established that TFIID promoter-binding activity as well as the function of TFIID-promoter complexes is tightly regulated through dynamic TFIID interactions with positive- and negative-acting transcription regulatory proteins. However, very little is known about the role of post-translational modifications in the regulation of TFIID. Here we show that the human TFIID subunits hsTAF5 and hsTAF12 are modified by the small ubiquitin-related modifier SUMO-1 in vitro and in human cells. We identify Lys-14 in hsTAF5 and Lys-19 in hsTAF12 as the primary SUMO-1 acceptor sites and show that SUMO conjugation has no detectable effect on nuclear import or intranuclear distribution of hsTAF5 and hsTAF12. Finally, we demonstrate that purified human TFIID complex can be SUMO-1-modified in vitro at both hsTAF5 and hsTAF12. We find that SUMO-1 conjugation at hsTAF5 interferes with binding of TFIID to promoter DNA, whereas modification of hsTAF12 has no detectable effect on TFIID promoter-binding activity. Our observations suggest that reversible SUMO modification at hsTAF5 contributes to the dynamic regulation of TFIID promoter-binding activity in human cells.
TFIID复合物由TATA结合蛋白(TBP)和TBP相关因子(TAFs)组成,是通用RNA聚合酶II(RNAP II)转录机制中唯一具有内在序列特异性DNA结合活性的成分。转录因子(TF)IID与蛋白质编码基因的核心启动子区域结合是RNAP II转录激活中的关键事件,也是转录起始复合物组装的第一步和限速步骤。过去的大量研究已证实,TFIID启动子结合活性以及TFIID-启动子复合物的功能通过TFIID与正负作用转录调节蛋白的动态相互作用受到严格调控。然而,关于翻译后修饰在TFIID调节中的作用知之甚少。在此我们表明,人TFIID亚基hsTAF5和hsTAF12在体外和人细胞中被小泛素相关修饰物SUMO-1修饰。我们确定hsTAF5中的赖氨酸-14和hsTAF12中的赖氨酸-19为主要的SUMO-1受体位点,并表明SUMO缀合对hsTAF5和hsTAF12的核输入或核内分布没有可检测到的影响。最后,我们证明纯化的人TFIID复合物在体外可在hsTAF5和hsTAF12处被SUMO-1修饰。我们发现hsTAF5处的SUMO-1缀合会干扰TFIID与启动子DNA的结合,而hsTAF12的修饰对TFIID启动子结合活性没有可检测到的影响。我们的观察结果表明,hsTAF5处的可逆SUMO修饰有助于人细胞中TFIID启动子结合活性的动态调节。